We Make Better Health Possible CONFI DENTI AL
Triventures Ò Investing in data-driven transformational health & medical devices Ò $130M under management (TV II $30M, TV III $100M) Ò Offices in Israel and Silicon Valley Ò New funds for the investment continuum, from seed to early & mid-stage 2
The Team Michal Geva Netalie Nadivi Dr. Peter Fitzgerald Dr. Marty Leon Nadav Klein, Ph.d. Principal Jim Gilbreath EIR Ted Tussing Associate Dan Goldsher CFO Karin Bar-Or Controller Lidia Verra Bookkeeper Eva Levy Office Manager 3
Healthcare Expertise Collectively, our team has: Ò Worked with > 300 global healthcare technologies around the globe Ò 100+ person years of experience working with healthcare start-ups Ò Experience transitioning 27 companies to 17 buyers and 4 IPOs Ò Advisory roles with FDA, Samsung, Livongo, Edwards Life Science, Novartis, Cardinal Health, Verb (Google) 4
Strategic LPs A key pillar of Triventures philosophy is tight alignment with industry leaders. Among our LPs, we are pleased to name tier one strategics in healthcare, consumer electronics and finance. Our LPs offer invaluable insights when we assess opportunities, with particular emphasis on commercial integration of novel technologies into markets. 5
Triventures Portfolio Transforming healthcare from life sciences to lifestyle 6
Digital Health Funding
Digital Health A Maturing Industry Transitioning from Pilot to Scale Ò 2017 global funding reached $11.5B, and $11.1B as of Q3-18 Ò 2017 Israel funding reached $325M, and $270M as of H1-18 Source: Start-Up Nation Central StartUp Health Insights 8
Main Funding Sources Friends & Family Incubator VC Private Equity Angel Accelerator Corporate / Strategic Non-Dilutive Funding 9
Fundraising Playbook Dos & Please Don t
Most Important Slide in Your Pitch? THE TEAM Ò Investors invest in people or ideas? Ò Investors prefer: o o Excellent idea + average team? Excellent team + average idea? 11
Know your audience Ò Prepare before your pitch o Know who you are pitching to o Read the bios and understand areas of interest Ò Tailor your pitch to your audience 12
Investors Want to? Ò Make money deliver returns to LPs Ò Your story needs to show a clear path to the money Ò An unmet need does not = market Ò Business model(s), scale, strategic partners, exit options Ò Success in Israel does not necessarily translate to success abroad 13
How to Handle Competition Ò We have no competition Ò Do not trash competition tell me how you are differentiated Ò Steer clear of overly-positive grids Feature Me Competitor 1 Competitor 2 Competitor 3 A B C D 14
Commercialization or Data Model? Ò There must be a data play Ò But never only a data play Ò Growing, scalable monetization business model should be foundation Ò Data opportunity is the pot of gold at the end of the rainbow 15
Surround Yourself with the Best Ò Hire up Ò Advisory board Ò Industry expert Ò Remember your ultimate goal should be to make the company a success Ò Engage the right people at the right time, even if they know more than you 16
Funding Planning & Valuation Ò Outline funding needs for the lifetime of the company Ò Always takes longer, costs more money Ò Plan to begin raising at least 6 mo prior to cash out Ò Always have a meaningful milestone achieved before asking for new money Ò Valuation should be linked to real achievements don t inflate 17
And a few more Ò Be weary of superlatives if you want to invest in a unicorn Ò Listen Ò Sometimes it s ok to say I don t know Ò VCs don t sign NDAs Ò Spell check 18
Thank You netalie@triventures.net CONFI DENTI AL